tulobuterol has been researched along with Chronic Disease in 1 studies
Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horiguchi, T | 1 |
| Kondo, R | 1 |
| Miyazaki, J | 1 |
| Fukumokto, K | 1 |
| Torigoe, H | 1 |
1 trial available for tulobuterol and Chronic Disease
| Article | Year |
|---|---|
Clinical evaluation of a transdermal therapeutic system of the beta2-agonist tulobuterol in patients with mild or moderate persistent bronchial asthma.
Topics: Administration, Cutaneous; Adult; Anti-Asthmatic Agents; Asthma; Blood Proteins; Bronchial Hyperreac | 2004 |